Enzo Biochem, Inc.
ENZB · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $82 | $22 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $30 |
| Receivables | $4 | $5 | $12 | $10 |
| Inventory | $7 | $8 | $15 | $13 |
| Other Curr. Assets | $7 | $3 | $6 | $4 |
| Total Curr. Assets | $70 | $98 | $54 | $71 |
| Property Plant & Equip (Net) | $15 | $17 | $32 | $34 |
| Goodwill | $0 | $0 | $7 | $7 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $5 | $1 | $1 |
| Tax Assets | $0 | $0 | -$1 | -$1 |
| Other NC Assets | $1 | $2 | $2 | $2 |
| Total NC Assets | $16 | $23 | $42 | $43 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $86 | $122 | $96 | $114 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $4 | $8 |
| Short-Term Debt | $1 | $2 | $5 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $12 | $0 | $3 |
| Other Curr. Liab. | $23 | $34 | $16 | $12 |
| Total Curr. Liab. | $25 | $40 | $25 | $26 |
| LT Debt | $3 | $7 | $12 | $19 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | -$3 | $5 | $0 |
| Total NC Liab. | $5 | $3 | $17 | $19 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $5 | $18 |
| Total Liabilities | $30 | $43 | $41 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$294 | -$268 | -$289 | -$270 |
| AOCI | $2 | $2 | $3 | $1 |
| Other Equity | $348 | $344 | $339 | $337 |
| Total Equity | $56 | $78 | $54 | $69 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $86 | $122 | $96 | $114 |
| Net Debt | -$49 | -$74 | -$5 | $9 |